Total
0
Shares
Beacon CBD +|O [2:100] Extra-strength CBD oil to help patients achieve their health objectives
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • VIVO Cannabis (VIVO) has launched its newest medical cannabis product formulation: high-dose cannabidiol (CBD) oil under its Beacon Medical™ brand
  • VIVO has also announced the launch of a Pediatric Compassionate Care Program to support caregivers and families
  • Beacon Medical™ products are available exclusively in select medical markets in Canada, Australia & Germany
  • Beacon Medical™ high CBD oil is available through the Canna Farms e-commerce medical marketplace for Canadian medical clients
  • VIVO Cannabis is recognized for trusted, premium cannabis products and services
  • VIVO Cannabis Inc. (VIVO) opened trading at C$0.09 per share

VIVO Cannabis (VIVO) has launched its newest medical cannabis product formulation: high-dose cannabidiol (CBD) oil under its Beacon Medical™ brand.

Beacon Medical™ 2:100 high-dose CBD oil is a distillate-based cannabis oil containing 100 mg CBD and less than 2 mg tetrahydrocannabinol (THC).

The entire family of Beacon Medical™ oil products are formulated using a non-GMO, food-grade medium-chain triglycerides (MCT) carrier oil which results in the final product being both scentless and flavourless in taste.

“With our commitment to the medical cannabis market, the team at VIVO aspires to deliver premium cannabinoid-based medical products to our patients, and the Beacon Medical™ CBD+ | O has been launched in response to patient insights our team has collected over time,” commented Ray Laflamme, Canna Farms’ Co-Founder and VIVO’s Chief Executive Officer.

“We recognize that many of our patients are looking for products that meet their individualized needs, and this latest addition to the Beacon Medical family of products is an excellent high potency CBD option for patients and it will be available to patients, doctors, and hospitals alike.”

VIVO has also announced the launch of a Pediatric Compassionate Care Program to support caregivers and families requiring medical cannabis to treat a variety of pediatric conditions. Eligible patients will receive substantial discounts off all Beacon Medical™, Canna Farms™, Fireside™ and Lumina™ CBD products.

Beacon Medical™ products are available exclusively in select medical markets in Canada, Australia & Germany.

The newly launched Beacon Medical™ high CBD oil is available through the Canna Farms e-commerce medical marketplace for Canadian medical clients.

VIVO Cannabis™ is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities.

VIVO Cannabis Inc. (VIVO) opened trading at C$0.09 per share.

More From The Market Herald
Theratechnologies - CEO, Paul Lévesque.

" Theratechnologies (TSX:TH) receives 2021 ADRIQ Innovation Award

Theratechnologies (TH) has taken home a 2021 ADRIQ Innovation Award in the Life Sciences category.
Eve and Co - CEO, Melinda Rombouts

" Eve & Co (TSXV:EVE) releases 2021 year-to-date financial results

Eve & Co (EVE) reported gross revenues of $6.5 million in the first nine months of 2021.

" Elixxer Ltd. (TSXV:ELXR) welcomes new director

Elixxer (ELXR) is pleased to welcome Mr. Jeremy Green to the corporation’s board of directors. 

" Psyence Group (CSE:PSYG) to speak at the annual Global Wellness Summit

Psyence Group (PSYG) will break new ground as the first psychedelic company invited to speak at the 15th Annual Global Wellness Summit.